The FANC B, E, F and G Genes and Their Products

  • Filippo Rosselli
Part of the Medical Intelligence Unit book series


Fanconi Anemia Complementation Group Bloom Syndrome Fanconi Anemia Pathway Fanconi Anemia Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ahmad SI, Hanaoka F, Kirk SH. Molecular biology of Fanconi anaemia—an old problem, a new insight. Bioessays 2002; 24:439–48.PubMedCrossRefGoogle Scholar
  2. 2.
    Alter BP. Cancer in Fanconi anemia 1927–2001. Cancer 2003; 97:425–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Blom E, van de Vrugt HJ, de Vries Y et al. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair (Amst) 2004; 3:77–84.PubMedCrossRefGoogle Scholar
  4. 4.
    Buchwald M, Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat Res 1998; 408:75–90.PubMedGoogle Scholar
  5. 5.
    Cumming RC, Lightfoot J, Beard K et al. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001; 7:814–20.PubMedCrossRefGoogle Scholar
  6. 6.
    D’Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003; 3:23–34.PubMedCrossRefGoogle Scholar
  7. 7.
    de Winter JP, Leveille F, van Berkel CG et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 2000a; 67:1306–8.PubMedGoogle Scholar
  8. 8.
    de Winter JP, Rooimans MA, van Der Weel L et al The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet 2000b; 24:15–6.PubMedCrossRefGoogle Scholar
  9. 9.
    de Winter JP, Waisfisz Q, Rooimans MA et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet 1998; 20:281–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Duckworth-Rysiecki G, Cornish K, Clarke CA et al. Identification of two complementation groups in Fanconi anemia. Somat Cell Mol Genet 1985; 11:35–41.PubMedCrossRefGoogle Scholar
  11. 11.
    Dufour C, Corcione A, Svahn J et al. TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood 2003; 102:2053–9, (Epub 2003 May 15).PubMedCrossRefGoogle Scholar
  12. 12.
    Fagerlie S, Lensch MW, Pang Q et al. The Fanconi anemia group C gene product: Signaling functions in hematopoietic cells. Exp Hematol 2001a; 29:1371–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Fagerlie SR, Diaz J, Christianson TA et al. Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes. Blood 2001b; 97:3017–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Faivre L, Guardiola P, Lewis C Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood 2000; 96:4064–70.PubMedGoogle Scholar
  15. 15.
    Fanconi anaemia/breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene. The Nat Genet 1996; 14:324–8.CrossRefGoogle Scholar
  16. 16.
    Futaki M, Igarashi T, Watanabe S et al. The FANCG Fanconi anemia protein interacts with CYP2E1: Possible role in protection against oxidative DNA damage. Carcinogenesis 2002; 23:67–72.PubMedCrossRefGoogle Scholar
  17. 17.
    Futaki M, Watanabe S, Kajigaya S et al. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment. Biochem Biophys Res Commun 2001; 281:347–51.PubMedCrossRefGoogle Scholar
  18. 18.
    Garcia-Higuera I, Kuang Y, Denham J et al. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 2000; 96:3224–30.PubMedGoogle Scholar
  19. 19.
    Garcia-Higuera I, Kuang Y, Naf D et al. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999; 19:4866–73.PubMedGoogle Scholar
  20. 20.
    Garcia-Higuera I, Taniguchi T, Ganesan S et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7:249–62.PubMedCrossRefGoogle Scholar
  21. 21.
    Godthelp BC, Artwert F, Joenje H et al. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 2002; 21:5002–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Gordon SM, Buchwald M. Fanconi anemia protein complex: Mapping protein interactions in the yeast 2-and 3-hybrid systems. Blood 2003; 102:136–41.PubMedCrossRefGoogle Scholar
  23. 23.
    Groves MR, Barford D. Topological characteristics of helical repeat proteins. Curr Opin Struct Biol 1999; 9:383–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Hoshino T, Wang J, Devetten MP et al. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood 1998; 91:4379–86.PubMedGoogle Scholar
  25. 25.
    Howlett NG, Taniguchi T, Olson S et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297:606–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Huber PA, Medhurst AL, Youssoufian H et al. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis. Biochem Biophys Res Commun 2000; 268:73–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Hussain S, Witt E, Huber PA et al. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet 2003; 5:5.Google Scholar
  28. 28.
    Joenje H, Oostra AB, Wijker M et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61:940–4.PubMedGoogle Scholar
  29. 29.
    Kruyt FA, Abou-Zahr F, Mok H et al. Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain. J Biol Chem 1999; 274:34212–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Kruyt FA, Hoshino T, Liu JM et al. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 1998; 92:3050–6.PubMedGoogle Scholar
  31. 31.
    Kuang Y, Garcia-Higuera I, Moran A et al. Carboxy terminal region of the Fanconi anemia protein FANCG/XRCC9 is required for functional activity. Blood 2000; 96:1625–32.PubMedGoogle Scholar
  32. 32.
    Lamb JR, Tugendreich S, Hieter P. Tetratrico peptide repeat interactions: To TPR or not to TPR? Trends Biochem Sci 1995; 20:257–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Levitus M, Rooimans MA, Steltenpool J et al. Heterogeneity in Fanconi anemia: Evidence for 2 new genetic subtypes. Blood 2004; 103:2498–503, (Epub 2003).PubMedCrossRefGoogle Scholar
  34. 34.
    Liu N, Lamerdin JE, Tucker JD et al. The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. Proc Natl Acad Sci USA 1997; 94:9232–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L et al. Expression cloning of a cDNA for the major Fanconi anaemia gene FAA. Nat Genet 1996; 14:320–3.Google Scholar
  36. 36.
    Meetei AR, de Winter JP, Medhurst AL et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003a; 35:165–70, (Epub 2003 Sep 14).PubMedCrossRefGoogle Scholar
  37. 37.
    Meetei AR, Sechi S, Wallisch M et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 2003b; 23:3417–26.PubMedCrossRefGoogle Scholar
  38. 38.
    Nakanishi K, Taniguchi T, Ranganathan V et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002; 4:913–20.PubMedCrossRefGoogle Scholar
  39. 39.
    Pace P, Johnson M, Tan WM et al. FANCE: The link between Fanconi anaemia complex assembly and activity. EMBO J 2002; 21:3414–23.PubMedCrossRefGoogle Scholar
  40. 40.
    Pagano G, Youssoufian H. Fanconi anaemia proteins: Major roles in cell protection against oxidative damage. Bioessays 2003; 25:589–95.PubMedCrossRefGoogle Scholar
  41. 41.
    Pang Q, Christianson TA, Keeble W et al. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J Biol Chem 2002; 277:49638–43, (Epub 2002 Oct 22).PubMedCrossRefGoogle Scholar
  42. 42.
    Pang Q, Christianson TA, Koretsky T et al. Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR. J Biol Chem 2003; 278:41709–17, (Epub 2003 Jul 25).PubMedCrossRefGoogle Scholar
  43. 43.
    Pang Q, Fagerlie S, Christianson TA et al. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol 2000; 20:4724–35.PubMedCrossRefGoogle Scholar
  44. 44.
    Pang Q, Keeble W, Christianson TA et al. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J 2001a; 20:4478–89.PubMedCrossRefGoogle Scholar
  45. 45.
    Pang Q, Keeble W, Diaz J et al. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. Blood 2001b; 97:1644–52.PubMedCrossRefGoogle Scholar
  46. 46.
    Pichierri P, Averbeck D, Rosselli F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum Mol Genet 2002; 11:2531–46.PubMedCrossRefGoogle Scholar
  47. 47.
    Pichierri P, Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 2004; 26:26.Google Scholar
  48. 48.
    Reuter T, Herterich S, Bernhard O et al. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system. Blood 2000; 95:719–20.PubMedGoogle Scholar
  49. 49.
    Reuter TY, Medhurst AL, Waisfisz Q et al. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Exp Cell Res 2003; 289:211–21.PubMedCrossRefGoogle Scholar
  50. 50.
    Rosselli F, Briot D, Pichierri P. The Fanconi anemia pathway and the DNA interstrand cross-links repair. Biochimie 2003; 85:1175–84.PubMedCrossRefGoogle Scholar
  51. 51.
    Rosselli F, Sanceau J, Gluckman E et al. Abnormal lymphokine production: A novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 1994; 83:1216–25.PubMedGoogle Scholar
  52. 52.
    Saar K, Schindler D, Wegner RD et al. Localisation of a Fanconi anaemia gene to chromosome 9p. Eur J Hum Genet 1998; 6:501–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Schultz JC, Shahidi NT. Tumor necrosis factor-alpha overproduction in Fanconi’s anemia. Am J Hematol 1993; 42:196–201.PubMedCrossRefGoogle Scholar
  54. 54.
    Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992a; 1:196–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Strathdee CA, Gavish H, Shannon WR et al. Cloning of cDNAs for Fanconi’s anaemia by functional complementation. Nature 1992b; 358:434.PubMedGoogle Scholar
  56. 56.
    Taniguchi T, D’Andrea AD. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 2002; 100:2457–62.PubMedCrossRefGoogle Scholar
  57. 57.
    Timmers C, Taniguchi T, Hejna J et al. Positional cloning of a novel Fanconi anemia gene FANCD2. Mol Cell 2001; 7:241–8.PubMedCrossRefGoogle Scholar
  58. 58.
    Tischkowitz MD, Hodgson SV. Fanconi anaemia. J Med Genet 2003; 40:1–10.PubMedCrossRefGoogle Scholar
  59. 59.
    Venkitaraman AR. Tracing the network connecting brca and fanconi anaemia proteins. Nat Rev Cancer 2004; 4:266–76.PubMedCrossRefGoogle Scholar
  60. 60.
    Waisfisz Q, de Winter JP, Kruyt FA et al. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci USA 1999a; 96:10320–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Waisfisz Q, Saar K, Morgan NV et al. The Fanconi anemia group E gene FANCE maps to chromosome 6p. Am J Hum Genet 1999b; 64:1400–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Yang Y, Kuang Y, De Oca RM et al. Targeted disruption of the murine Fanconi anemia gene Fancg/Xrcc9. Blood 2001; 98:3435–40.PubMedCrossRefGoogle Scholar
  63. 63.
    Zunino A, Degan P, Vigo T et al. Hydrogen peroxide: Effects on DNA chromosomes cell cycle and apoptosis induction in Fanconi’s anemia cell lines. Mutagenesis 2001; 16:283–8.PubMedCrossRefGoogle Scholar

Copyright information

© and Springer Science+Business Media 2006

Authors and Affiliations

  • Filippo Rosselli
    • 1
  1. 1.Laboratory of Genetic Stability and Cancer, UPR 2169, CNRSGustave Roussy Institute PR2VillejuifFrance

Personalised recommendations